CHARLIE’S HOLDINGS, INC.

CHUC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $3.8M $4.8M $10.5M $7.1M $1.8M $1.6M $1.0M $1.6M
Cost of Revenue $2.7M $3.6M $7.5M $5.3M $1.3M $1.2M $994.0K
Gross Profit $1.1M $1.2M $3.0M $1.8M $486.0K $386.0K $630.0K
Gross Margin 29.4% 24.6% 28.8% 24.9% 27.6% 24.5% 38.8%
Operating Expenses
Research & Development
SG&A Expense $1.9M $1.7M $2.2M $1.7M $1.4M $1.1M $1.2M $1.4M
Operating Income $-1.2M $-975.0K $7.0K $-339.0K $-954.0K $-879.0K $-751.0K $-876.0K
Operating Margin -32.5% -20.3% 0.1% -4.8% -54.2% -55.7% -71.7% -53.9%
Interest Expense
Pretax Income $-1.7M $-1.1M $-74.0K $624.0K $5.3M $-1.3M $-1.0M
Income Tax Expense $0 $0 $-113.0K $0 $388.0K $0 $0
Net Income $-1.7M $-1.1M $131.0K $624.0K $5.0M $-1.2M $-1.1M $-1.0M
Net Margin -43.7% -21.9% 1.2% 8.8% 281.7% -77.1% -107.4% -62.9%
EPS (Basic) $-0.01 $0.00 $0.01 $0.00 $0.02 $-0.01 $-0.02 $0.00
EPS (Diluted) $0.02 $0.00 $0.00 $0.00 $-0.02 $0.00
Shares Outstanding (Basic) 274.1M 268.1M 257.4M 256.3M 254.4M 253.6M 234.8M 242.6M
Shares Outstanding (Diluted) 274.1M 268.1M 278.5M 277.6M 282.0M 253.6M 234.8M 242.6M
Dividends Per Share
← Newer Page 1 of 8 Older →